Header Logo

Connection

Idoroenyi Amanam to Biomarkers, Tumor

This is a "connection" page, showing publications Idoroenyi Amanam has written about Biomarkers, Tumor.
Connection Strength

0.366
  1. Mutation and immune profiling of metaplastic breast cancer: Correlation with survival. PLoS One. 2019; 14(11):e0224726.
    View in: PubMed
    Score: 0.152
  2. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. Am J Clin Oncol. 2019 04; 42(4):337-344.
    View in: PubMed
    Score: 0.145
  3. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol. 2019 07 01; 30(7):1096-1103.
    View in: PubMed
    Score: 0.037
  4. Current and future therapies for advanced pancreatic cancer. J Surg Oncol. 2017 Jul; 116(1):25-34.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.